Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 2 (2005), Issue 6 (June)

1. Immunohistochemical detection of the beta4 integrin subunit in pancreatic adenocarcinoma.
   J Histochem Cytochem, 53(6): 799-801. [Abstract] [Full-text]
2. Immunotherapy for pancreatic cancer - science driving clinical progress.
   Nat Rev Cancer, 5(6): 459-67. [Abstract] [Full-text]
3. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies.
   Br J Cancer, 92(11): 2076-83. [Abstract] [Full-text]
4. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
   Cancer Res, 65(11): 4870-80. [Abstract] [Full-text]
5. EUS diagnosis of vascular invasion in pancreatic cancer: surgical and histologic correlates.
   Am J Gastroenterol, 100(6): 1381-5. [Abstract] [Full-text]
6. Three-dimensional linear endoscopic ultrasound-feasibility of a novel technique applied for the detection of vessel involvement of pancreatic masses.
   Am J Gastroenterol, 100(6): 1296-302. [Abstract] [Full-text]
7. Para-aortic lymph node metastasis in carcinoma of the head of the pancreas.
   Surgery, 137(6): 606-11. [Abstract] [Full-text]
8. Solid pseudopapillary neoplasms of the pancreas: is there a pathologic basis for the observed gender differences in incidence?
   Surgery, 137(6): 591-6. [Abstract] [Full-text]
9. "Sugar" tumor of the pancreas: a rare entity that is diagnosable on preoperative fine-needle biopsies.
   Virchows Arch, 446(5): 555-9. [Abstract] [Full-text]
10. Differential diagnosis of pancreatic tumors using ultrasound contrast imaging.
    J Gastroenterol, 40(5): 518-25. [Abstract] [Full-text]
11. Comparative genomic hybridization analysis for pancreatic cancer specimens obtained by endoscopic ultrasonography-guided fine-needle aspiration.
    J Gastroenterol, 40(5): 511-7. [Abstract] [Full-text]
12. 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer.
    Cancer Epidemiol Biomarkers Prev, 14(6): 1470-6. [Abstract] [Full-text]
13. Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin.
    Cancer, 103(12): 2485-90. [Abstract] [Full-text]
14. Optimized normalization for antibody microarrays and application to serum-protein profiling.
    Mol Cell Proteomics, 4(6): 773-84. [Abstract] [Full-text]
15. Expression pattern of keratin subclasses in pancreatoblastoma with special emphasis on squamoid corpuscles.
    Pathol Int, 55(6): 297-302. [Abstract] [Full-text]
16. Risk factors for pancreatic cancer.
    J Cell Biochem, 95(4): 649-56. [Abstract] [Full-text]
17. Is bortezomib, a proteasome inhibitor, effective in treating cancer-associated weight loss? Preliminary results from the North Central Cancer Treatment Group.
    Support Care Cancer, 13(6): 381-6. [Abstract] [Full-text]
18. Malign cystic glucagonoma presented with diabetic ketoacidosis: case report with an update.
    Endocr Relat Cancer, 12(2): 449-54. [Abstract] [Full-text]
19. Chromosomal instability predicts metastatic disease in patients with insulinomas.
    Endocr Relat Cancer, 12(2): 435-47. [Abstract] [Full-text]
20. Neural cell adhesion molecule-deficient beta-cell tumorigenesis results in diminished extracellular matrix molecule expression and tumour cell-matrix adhesion.
    Tumour Biol, 26(2): 103-12. [Abstract] [Full-text]
21. Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer.
    Oncogene, 24(22): 3652-6. [Abstract] [Full-text]
22. Neutral lipid isolated from endosperm of Job's tears inhibits the growth of pancreatic cancer cells via apoptosis, G2/M arrest, and regulation of gene expression.
    J Gastroenterol Hepatol, 20(7): 1046-53. [Abstract] [Full-text]
23. Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.
    Br J Cancer, 92(12): 2134-9. [Abstract] [Full-text]
24. Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients.
    Br J Cancer, 92(12): 2225-32. [Abstract] [Full-text]
25. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells.
    Cancer Res, 65(12): 5238-47. [Abstract] [Full-text]
26. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
    Cancer Res, 65(12): 5045-53. [Abstract] [Full-text]
27. Cepharanthine potently enhances the sensitivity of anticancer agents in K562 cells.
    Cancer Sci, 96(6): 372-6. [Abstract] [Full-text]
28. A novel retinoid-related molecule inhibits pancreatic cancer cell proliferation by a retinoid receptor independent mechanism via suppression of cell cycle regulatory protein function and induction of caspase-associated apoptosis.
    Oncogene, 24(26): 4257-70. [Abstract] [Full-text]
29. Parathyroid hormone-related protein (PTHrP) as a causative factor of cancer-associated wasting: possible involvement of PTHrP in the repression of locomotor activity in rats bearing human tumor xenografts.
    Int J Cancer, 116(3): 471-8. [Abstract] [Full-text]
30. Malignant biliary obstruction: value of imaging findings.
    Abdom Imaging, 30(3): 314-23. [Abstract] [Full-text]
31. Molecular dissection of a medicinal herb with anti-tumor activity by oligonucleotide microarray.
    Life Sci, 77(9): 991-1002. [Abstract] [Full-text]
32. Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer.
    Arch Surg, 140(6): 584-9; discussion 589-91. [Abstract] [Full-text]
33. Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: evidence of homozygous deletion in a noninvasive precursor lesion.
    Mod Pathol, 18(7): 959-63. [Abstract] [Full-text]
34. Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis.
    Oncogene, 24(27): 4421-32. [Abstract] [Full-text]
35. Serous cystadenocarcinoma of the pancreas.
    Pathol Int, 55(7): 436-9. [Abstract] [Full-text]
36. Photodynamic effects of a novel pterin derivative on a pancreatic cancer cell line.
    Biochem Biophys Res Commun, 333(3): 763-7. [Abstract] [Full-text]
37. Expression of E-cadherin and uPA and their association with the prognosis of pancreatic cancer.
    Jpn J Clin Oncol, 35(6): 342-8. [Abstract] [Full-text]

© 2004-2008 Pancreatic Cancer Research Today. All Rights Reserved.